{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02916433","recordId":"NCT02916433","peptideSlug":"octreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02916433-octreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02916433.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02916433.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-09-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"octreotide","submittedDate":"2016-09-26","publishedAt":"2026-08-23","recordId":"NCT02916433","recordSha256":"559ccb0ac1bf409e05da1dfef37d6794efd8d642b6762cb2b3a3505b99f765c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02916433?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"octreotide","submittedDate":"2016-09-27","publishedAt":"2026-08-23","recordId":"NCT02916433","recordSha256":"0c980f75162705cba36c9405f22c95250eec09e6fb7faf683721c5dab8854f36","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02916433?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2020-08-27","publishedAt":"2026-08-23","recordId":"NCT02916433","recordSha256":"0a4e07392acd3ea39eeacee96f46b34f15348b39162514f3b8e534c24aab22ce","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02916433?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2020-09-16","publishedAt":"2026-08-23","recordId":"NCT02916433","recordSha256":"6fc39d8835e4e9db61b6a6e833c6fa10990f700c4442dc5aaf9801f9ca0257f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02916433?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"46c7d7cfa43eae8a805575ef4816b7cae71cacc1ce63740a02e494343ba1c8d1"}}